Foods and beverages, including bakery, nutrition bar, and cereal and pasta products, can now use the claim.
Photo © iStockphoto.com/evgenyb
Ingredion Inc.’s (Westchester, IL) Hi-Maize high-amylose maize resistant starch has a newly approved qualified health claim from FDA linking the ingredient with a reduction in the risk of type 2 diabetes.
Foods and beverages-including bakery, nutrition bar, and cereal and pasta products-using Hi-Maize can now use the claims:
According to Ingredion, FDA based its assessment on eight clinical trials showing the positive impact of Hi-Maize on insulin sensitivity and other biomarkers related to blood sugar.
“We believe the new qualified health claim is a positive development for consumers as it provides another pragmatic approach to potential diabetes risk reduction through everyday foods,” said Lorraine Niba, PhD, global director, nutrition springboard, for Ingredion.
Also read:
Acacia Gum Granted EU Health Claim for Glycemic Reduction
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
What's next for NPA and CRN in their complaints against New York state?
May 2nd 2024The latest updates in the efforts of the Natural Products Association and the Council for Responsible Nutrition to sue New York state for its law banning the sale of weight management and muscle building supplements to minors.
Woodland Foods acquires Idan Foods to expand further into foodservice and industrial channels
April 29th 2024Woodland Foods, a provider of globally-sourced, plant-based ingredients has announced the acquisition of Idan Foods, which provides breading and batters, coating systems, baking mixes, and seasonings.